SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-06-29
👔
Parabilis Medicines, Inc.
@PBLS_InsiderForm 4 Filing: Soleus PE GP III, LLC Buys $15.0M of $PBLS
INSIDER PURCHASE
⚡ MATERIALITY: 8/10
corporate issuer
Parabilis Medicines, Inc.
Ticker: $PBLS
Transaction Value
$15.0M
Price/Share: $14.60
transaction date
2026-06-11
Shares: 1,027,070
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Soleus PE GP III, LLC, holds the title of 10% Owner at Parabilis Medicines, Inc..
On 2026-06-11, the insider transacted 1,027,070 shares.The shares were transacted at a weighted average price of $14.60 per share, resulting in a total market-relevant value of $15.0M.
Executive Summary Summary
Soleus PE GP III, LLC (10% Owner) bought $15.0M of $PBLS
Post-Transaction Position: 1,027,000 shares
SEC Accession No: 0001213900-26-072928 (CIK: 2088815)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.